You did not “catch” IBS from a single bad meal or a stomach bug alone. Irritable bowel syndrome most often emerges when several ordinary factors converge: a gut that became hypersensitive after infection or stress, a microbiome shifted out of balance, a gut-brain signaling loop stuck in high alert, and sometimes genes or early-life experiences that set the threshold lower. No single cause explains every case, and no test confirms it—which is exactly why the question “How did I get IBS?” has a mechanistic answer rather than a single culprit.

The Gut-Brain Axis and Visceral Hypersensitivity

IBS is best understood as a disorder of communication between the gut and the central nervous system, not a structural disease of the bowel. In most people with IBS, the intestines look normal on imaging and scope. What differs is how the gut senses and reports what is happening inside it. This is called visceral hypersensitivity: normal amounts of gas, stretching, or motility are perceived as pain or urgency.

The mechanism runs in both directions. The enteric nervous system—roughly 500 million neurons embedded in the gut wall—continuously sends signals up the vagus nerve and spinal pathways to the brain. The brain, in turn, sends descending signals that modulate gut motility, secretion, and pain perception. In IBS, this loop appears dysregulated. Brain imaging studies show altered activation in regions that process visceral sensation and threat, and the result is a gut that reacts to stimuli that other people barely notice.

Stress is not “all in your head” in the dismissive sense. Corticotropin-releasing factor and the hypothalamic-pituitary-adrenal axis directly change gut motility, permeability, and mast cell activity. Chronic stress can therefore produce real, measurable changes in how the intestine behaves. Put plainly: the brain can turn up the volume on gut signals, and the gut can turn up the volume on brain signals.

Quantified Context: Who Gets IBS and How Common It Is

IBS is one of the most common functional gastrointestinal disorders worldwide. Pooled global estimates place prevalence around 4 to 10 percent of adults depending on the diagnostic criteria used, with some regions reporting higher figures. In the United States, large survey data suggest roughly 10 to 15 percent of adults meet criteria for IBS at some point, though only a fraction seek care.

The sex distribution is skewed: women are diagnosed about two to three times as often as men in clinical settings, a pattern that likely reflects both biological and care-seeking differences. Onset most commonly occurs between ages 20 and 50, but IBS can begin at any age, and new onset after age 50 warrants evaluation for other causes.

The economic burden is substantial. Direct and indirect costs in the US are estimated in the billions of dollars annually when accounting for office visits, testing, prescriptions, and lost work productivity. These figures vary by study and year, so treat any single number as an estimate rather than a fixed constant. What is stable is the pattern: IBS is common, chronic, and costly, and it disproportionately affects quality of life.

Post-Infectious IBS: When a Bug Leaves a Lasting Trace

One of the clearest causal pathways is post-infectious IBS. A bout of bacterial gastroenteritis—commonly from Campylobacter, Salmonella, or Shigella—can trigger persistent IBS symptoms in a subset of people. Estimates suggest roughly 10 percent of people who experience a confirmed bacterial gastrointestinal infection go on to develop IBS symptoms, though reported rates range widely depending on the pathogen and follow-up period.

The mechanism involves lingering low-grade inflammation, increased intestinal permeability, and altered enterochromaffin cell function that changes serotonin signaling in the gut. Even after the infection clears, mast cells remain activated and the gut mucosa stays in a mildly inflamed state. This is one reason a person can trace their IBS back to a specific trip or illness and still be told their tests are normal.

The counterintuitive detail: the severity of the initial infection does not reliably predict who develops post-infectious IBS. Host factors—anxiety, somatization, and genetic predisposition—appear to matter as much as the pathogen itself. So a mild infection in a vulnerable host can produce lasting symptoms, while a severe infection in a resilient host may resolve completely.

Microbiome Shifts, Fermentable Sugars, and Gas

The gut microbiome in IBS differs from that of healthy controls in composition and stability, though no single “IBS microbiome” signature has been validated for diagnosis. What matters mechanistically is function: how bacteria ferment dietary carbohydrates and how the host responds to the resulting gas.

Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols—collectively FODMAPs—are poorly absorbed short-chain carbohydrates. When they reach the colon, bacteria ferment them rapidly, producing hydrogen, methane, and carbon dioxide. In a normal gut this causes mild bloating. In a hypersensitive gut, the same gas load produces pain, distension, and urgency. This is why a low-FODMAP diet helps a substantial subset of people with IBS: it reduces the substrate for fermentation rather than treating an infection.

Small intestinal bacterial overgrowth, or SIBO, is often invoked as a cause of IBS, but the evidence is mixed. Breath testing for SIBO has significant limitations, and antibiotic trials show inconsistent results. The professional caveat here is important: SIBO may explain some IBS-like symptoms in some patients, but it is not a universal explanation, and overdiagnosis leads to unnecessary antibiotic exposure.

Timeline: How IBS Develops and Persists

Stage What Happens Typical Timeframe
Trigger Infection, stress event, antibiotic course, or dietary change Days to weeks
Acute perturbation Mucosal inflammation, microbiome disruption, altered motility Days to weeks after trigger
Sensitization Nerve endings become hypersensitive; mast cells stay activated Weeks to months
Chronification Gut-brain loop reinforces symptom perception and avoidance Months
Plateau Symptoms stabilize into a recognizable pattern 6 to 12 months
Fluctuation Remissions and flares tied to stress, diet, hormones Ongoing, years

This timeline is a general pattern, not a rule. Some people develop symptoms gradually without an identifiable trigger, and others fluctuate for years before seeking care. The key mechanistic point is that IBS is not a static condition—it is a dynamic interaction between a sensitized gut and a reactive brain, and both sides of that loop can change over time.

Edge Cases: When It Is Not IBS

Several conditions mimic IBS and must be excluded before the diagnosis is made. Celiac disease affects roughly 1 percent of the population and can present with bloating, diarrhea, and abdominal pain that overlap almost entirely with IBS. Inflammatory bowel disease—Crohn’s disease and ulcerative colitis—can begin with IBS-like symptoms, particularly in young adults. Microscopic colitis causes chronic watery diarrhea, especially in older adults, and is diagnosed only by biopsy.

Other mimics include bile acid diarrhea, which affects a meaningful proportion of people labeled with IBS with diarrhea, and carbohydrate malabsorption such as lactose intolerance. Thyroid disease, diabetes-related neuropathy, and gynecologic conditions can also produce overlapping symptoms. This is why the Rome IV criteria emphasize symptom patterns plus the absence of alarm features rather than a positive test.

Red-flag warnings that require prompt medical evaluation rather than an IBS label:

Rectal bleeding or black, tarry stools Unintentional weight loss New symptoms after age 50 Anemia on blood tests Nocturnal diarrhea that wakes you from sleep Family history of colorectal cancer or inflammatory bowel disease

These features do not mean you have a dangerous condition, but they change the diagnostic pathway from “likely IBS” to “rule out organic disease first.”

Misconceptions About How IBS Starts

The most persistent misconception is that IBS is caused by anxiety or is “just stress.” Stress modulates IBS, but it does not fully explain it. Many people with high stress never develop IBS, and many with IBS have no significant anxiety. The relationship is bidirectional and mediated by measurable physiology, not weakness.

A second misconception is that a specific food “caused” IBS. Food can trigger symptoms, and dietary changes can worsen or improve them, but no single food creates the disorder. The low-FODMAP diet reduces symptoms in a subset of people, but it is a management strategy, not a cure, and long-term restriction can reduce microbiome diversity.

A third misconception is that IBS is not a real disease because tests are normal. Functional disorders are defined by disordered function, not visible structural damage. The absence of inflammation on biopsy does not mean the gut is behaving normally—it means the abnormality is in signaling, motility, and sensitivity rather than in tissue architecture.

Practical Actions and What the Evidence Supports

If you are trying to understand your own symptoms, the most useful steps are diagnostic and behavioral rather than speculative. Keep a symptom diary for two to four weeks tracking food, stress, sleep, and bowel patterns. This helps identify triggers and gives a clinician concrete data.

Ask your clinician whether you meet Rome IV criteria for IBS, which require recurrent abdominal pain at least one day per week in the last three months, associated with two or more of: relation to defecation, change in stool frequency, or change in stool form. If alarm features are present, push for appropriate testing before accepting an IBS label.

Evidence-supported management includes soluble fiber supplementation, peppermint oil, certain antispasmodics, and gut-directed psychotherapy such as cognitive behavioral therapy or gut-directed hypnotherapy. A structured low-FODMAP trial with a dietitian typically lasts four to six weeks for the elimination phase, followed by systematic reintroduction. Probiotics have mixed evidence and strain-specific effects, so blanket recommendations are not well supported. Medications exist for specific IBS subtypes, but they require clinical evaluation and are outside the scope of general guidance.

Limitations: What Science Has Not Settled

The honest answer to “How did I get IBS?” is that for most individuals, no single cause can be identified with certainty. The mechanisms are well described at the population level, but applying them to one person is imprecise. There is no biomarker, no diagnostic test, and no cure. Genetic studies have identified risk variants, but effect sizes are small and not clinically actionable.

Research continues on the roles of bile acids, serotonin signaling, intestinal permeability, and the microbiome, but much of it is preliminary. Anyone who claims a definitive cause or a universal cure is overselling the evidence. The most defensible position is that IBS arises from a combination of host susceptibility, environmental triggers, and gut-brain dysregulation—and that understanding those mechanisms is useful for management even when it does not yield a single origin story.